Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89351-89400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05167786
Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke
NARecruiting
115 participants
Started: Mar 1, 2022 · Completed: Aug 25, 2027
1 condition2 sponsors1 location
NCT05579717
Examining the Effectiveness of EAL
NAActive, not recruiting
40 participants
Started: Mar 1, 2022 · Completed: Aug 31, 2025
1 condition3 sponsors1 location
NCT05074381
Dry Needling of the M. Obliquus Capitis Inferior on Rotational Mobility and Headache Related Outcome Measures in CH.
NARecruiting
60 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05116137
The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
NAEnrolling by invitation
24 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06305858
Partial Versus Total Knee Replacement in Bicompartmental Gonarthrosis (Medial and Patellofemoral): Prospective Functional Assessment Study
NARecruiting
48 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06137404
A Comparison of Metacarpophalangeal Joint Blocking Splint With Relative Motion Extension Splint for Trigger Finger
NAEnrolling by invitation
30 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT05262673
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
PHASE1Recruiting
10 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05027763
Effect of Preoperative Diet on Perioperative Gut Microbiome
NAActive, not recruiting
60 participants
Started: Mar 1, 2022 · Completed: Sep 20, 2025
1 condition1 sponsor1 location
NCT05297331
Renal Stone Treatment Global Registry
N/ARecruiting
3,000 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2033
1 condition1 sponsor3 locations
NCT04293016
Building Resilience In Caregivers of Trauma Survivors
NAActive, not recruiting
300 participants
Started: Mar 1, 2022 · Completed: Aug 26, 2024
1 condition2 sponsors1 location
NCT05192603
Comparison Between Low FODMAP and SSRD in IBS
NAEnrolling by invitation
200 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2029
1 condition1 sponsor1 location
NCT05124808
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
NARecruiting
828 participants
Started: Mar 1, 2022 · Completed: Apr 8, 2026
3 conditions6 sponsors5 locations
NCT05251324
The Cardiovascular Impact of Hot Flushes
N/ARecruiting
60 participants
Started: Mar 1, 2022 · Completed: May 26, 2026
2 conditions1 sponsor1 location
NCT03105843
Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol
PHASE4Recruiting
30 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT05128032
Pressure-enabled Delivery in Radioembolization (TriNav Study)
NAActive, not recruiting
20 participants
Started: Mar 1, 2022 · Completed: Jun 1, 2026
3 conditions2 sponsors2 locations
NCT06680739
Single cEll pRofiling PErsistaNce To ImmuNothErapy
PHASE2Recruiting
60 participants
Started: Mar 1, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05310838
Optimizing Engagement in Services for First-Episode Psychosis
NARecruiting
58 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2026
2 conditions4 sponsors2 locations
NCT04929899
Bright Ideas - CIN Feasibility Study
NARecruiting
75 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2025
1 condition4 sponsors4 locations
NCT06294379
Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy
N/ARecruiting
150 participants
Started: Mar 1, 2022 · Completed: Dec 30, 2024
1 condition4 sponsors1 location
NCT05264961
Behavioral Abnormalities in Dysphonic Children
NAActive, not recruiting
25 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05350475
Protons Vs. Photons for High-risk Prostate Cancer
NARecruiting
400 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2037
2 conditions8 sponsors7 locations
NCT05176847
The Mobile Lifestyle Intervention for Food and Exercise Study
NAActive, not recruiting
240 participants
Started: Mar 1, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05332782
Outcomes of Patients tReated wIth Mitral Transcatheter Edge-to-edge Repair for Primary Mitral Regurgitation Registry
N/ARecruiting
2,000 participants
Started: Mar 1, 2022 · Completed: Jan 1, 2026
1 condition1 sponsor6 locations
NCT05459753
Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)
NAActive, not recruiting
125 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05685784
Multiple Sclerosis Prediction and Monitoring of Progression Study
NARecruiting
70 participants
Started: Mar 1, 2022 · Completed: Sep 30, 2024
1 condition3 sponsors1 location
NCT05243550
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PHASE3Active, not recruiting
240 participants
Started: Mar 1, 2022 · Completed: Feb 29, 2028
3 conditions1 sponsor65 locations
NCT05849597
Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery
PHASE3Recruiting
200 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05248165
Naples PCI Registry
N/ARecruiting
5,000 participants
Started: Mar 1, 2022 · Completed: Mar 30, 2032
5 conditions1 sponsor1 location
NCT05429736
Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity
NARecruiting
28 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2026
2 conditions2 sponsors1 location
NCT06931548
Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery
NARecruiting
100 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT05249075
Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy
N/AActive, not recruiting
150 participants
Started: Mar 1, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT04260256
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
PHASE2Recruiting
40 participants
Started: Mar 1, 2022 · Completed: Nov 30, 2026
1 condition3 sponsors2 locations
NCT05245318
The CATT Trial: Cost-effectiveness of a Smartphone Application for Tinnitus Treatment
NARecruiting
334 participants
Started: Mar 1, 2022 · Completed: Dec 1, 2025
1 condition4 sponsors1 location
NCT05133726
Peer and Text Message Support to Reduce Readmission Rates for Patients Discharged From Acute Psychiatric Care
NAActive, not recruiting
1,132 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors7 locations
NCT05022264
Remote Investigation and Assessment of Vital Signs
N/ARecruiting
860 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2027
5 conditions2 sponsors1 location
NCT06301191
The Effect of Semaglutide on Cardiovascular Markers and Liver Function
N/ARecruiting
50 participants
Started: Mar 1, 2022 · Completed: May 1, 2024
1 condition1 sponsor1 location
NCT05177211
Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
PHASE2Active, not recruiting
25 participants
Started: Mar 1, 2022 · Completed: Apr 30, 2026
3 conditions2 sponsors3 locations
NCT06549803
Comparison of Method for Skin Closure in Colorectal Cancer.
NAEnrolling by invitation
304 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05644548
Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
N/ARecruiting
300 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT03862924
Health Effects of the Standardized Research E-Cigarette in Smokers With HIV Smokers With HIV
NARecruiting
72 participants
Started: Mar 1, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05053997
Navigate - Improving Survival in Vulnerable Lung Cancer Patients
NARecruiting
518 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2026
1 condition5 sponsors6 locations
NCT05032053
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
N/ARecruiting
3,000 participants
Started: Mar 1, 2022 · Completed: Oct 1, 2026
1 condition3 sponsors16 locations
NCT04998682
Prospective Evaluation of Targeted Axillary Dissection (TAD)
NARecruiting
45 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06554925
SEx-specific Differences in Cardiac Surgery Patients (SECS).
N/ARecruiting
10,000 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2031
3 conditions1 sponsor1 location
NCT05958043
Performance of CAD/CAM Milled and 3D-printed Full-arch Implant-supported Provisionals Restorations
NARecruiting
20 participants
Started: Mar 1, 2022 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT05267379
An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis
N/ARecruiting
700 participants
Started: Mar 1, 2022 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT05247125
The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)
PHASE4Recruiting
80 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06309251
Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
N/ARecruiting
100 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor3 locations
NCT05147844
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
PHASE2Recruiting
40 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2026
1 condition4 sponsors2 locations
NCT05231850
A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage Ⅱ and Stage Ⅲ Colon Cancer and dMMR/MSI.
PHASE2Not yet recruiting
70 participants
Started: Mar 1, 2022 · Completed: Sep 1, 2027
1 condition1 sponsor0 locations